keyword
MENU ▼
Read by QxMD icon Read
search

gastric antral vascular ectasia

keyword
https://www.readbyqxmd.com/read/27903032/-interventional-left-atrial-appendage-closure-in-a-patient-with-gave-syndrome
#1
Christian Fastner, Sebastian Belle, Ibrahim Akin
History and findings | A 56-year-old female with a gastric antral vascular ectasia (GAVE) suffered from recurrent episodes of upper gastrointestinal bleeding. Because of a history of a permanent atrial fibrillation (CHA2DS2-VASc score 3 points) an oral anticoagulation therapy with phenprocoumon was carried out which even worsened the bleeding frequency and intensity. A change of medication to low-molecular weight heparin did not lead to success. The frequent periods in hospital limited the patient's quality of life...
November 2016: Deutsche Medizinische Wochenschrift
https://www.readbyqxmd.com/read/27871022/vascular-targeted-photodynamic-therapy-of-gastric-antral-vascular-ectasia-gave
#2
Haixia Qiu, Yongping Mao, Jing Zeng, Ying Wang, Jiaying Zhang, Naiyang Huang, Qingsen Liu, Yunsheng Yang, Enqiang Linghu, Ying Gu
BACKGROUND AND STUDY AIM: Vascular-targeted photodynamic therapy (V-PDT) has been used for several benign vascular diseases. The aim of this pilot study was to demonstrate the potential benefits of VPDT in the treatment of gastric antral vascular ectasia (GAVE). PATIENTS AND METHODS: Data from patients with GAVE (n=5) who underwent endoscopic V-PDT were analyzed retrospectively. Pre- and post-V-PDT clinical and endoscopic features, hemoglobin levels, and transfusion requirement were compared...
October 29, 2016: Journal of Photochemistry and Photobiology. B, Biology
https://www.readbyqxmd.com/read/27830096/hemorrhage-from-extra-antral-gastric-antral-vascular-ectasia-in-a-patient-with-duodenal-heterotopic-gastric-mucosa
#3
John Gubatan, Nathan Raines, Hasan Khosravi, Tracy L Challies, Tyler M Berzin
Gastric antral vascular ectasias (GAVE) have been increasingly recognized as an uncommon cause of chronic gastrointestinal bleeding and anemia, although their underlying pathogenesis is not completely well understood. Heterotopic gastric mucosa (HGM) has been reported to occur at various sites along the gastrointestinal tract and although relatively common, it is often asymptomatic. We report a case of a 60-year-old woman with a prior history of GAVE who developed melena and symptomatic anemia during her hospitalization following cardiac catheterization...
2016: Case Reports in Gastrointestinal Medicine
https://www.readbyqxmd.com/read/27793944/imatinib-induced-gastrointestinal-vascular-ectasia-in-a-patient-with-advanced-gist-case-report-and-literature-review
#4
Mahmoud Abu-Amna, Halim Awadie, Gil Bar-Sela
BACKGROUND: Imatinib is generally well tolerated in the treatment of advanced gastrointestinal stromal tumors (GIST). Gastrointestinal vascular ectasia (GIVE) and gastric antral vascular ectasia (GAVE), while rare, are significant under-reported complications of imatinib therapy. CASE REPORT: We present one patient with GIVE complicating imatinib therapy with a literature review of this rare side-effect. RESULTS: A 68-year-old woman was diagnosed with advanced GIST, wild-type CKIT...
November 2016: Anticancer Research
https://www.readbyqxmd.com/read/27788611/helicobacter-pylori-liver-cirrhosis-and-portal-hypertension-an-updated-appraisal
#5
Raffaele Licinio, Giuseppe Losurdo, Sonia Carparelli, Andrea Iannone, Floriana Giorgio, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo
OBJECTIVE: Helicobacter pylori (H. pylori) is the most common cause of gastritis and peptic ulcer. However, H. pylori is even involved in extragastric diseases, and it has been hypothesized that H. pylori could be a risk factor for several hepatic diseases. For instance, a direct involvement of H. pylori in the development of portal hypertension (PH) in cirrhotic patients has been postulated. METHODS: We performed a literature search in major databases to elucidate the relationship between H...
October 27, 2016: Immunopharmacology and Immunotoxicology
https://www.readbyqxmd.com/read/27728256/gastric-antral-vascular-ectasia
#6
Satyajeet Nighute, G S Shiddhapur
No abstract text is available yet for this article.
January 2016: Journal of the Association of Physicians of India
https://www.readbyqxmd.com/read/27669532/radiofrequency-ablation-of-gastric-antral-vascular-ectasia-of-the-gastric-cardia
#7
Arvind J Trindade, Sumant Inamdar, David Magier
No abstract text is available yet for this article.
January 2016: Endoscopy
https://www.readbyqxmd.com/read/27595456/gastrointestinal-bleeding-from-vascular-malformations-is-octreotide-effective-to-rescue-difficult-to-treat-patients
#8
Andrea Iannone, Mariabeatrice Principi, Michele Barone, Giuseppe Losurdo, Enzo Ierardi, Alfredo Di Leo
Gastrointestinal vascular malformations are responsible for 2-8% of all cases of bleeding and 30-40% of all obscure hemorrhages, being the most frequent cause of occult bleeding in older people. The aim of this review was to provide an up-to-date report about the use of octreotide in bleeding from both hereditary and acquired vascular malformations of the gastrointestinal tract. A systematic literature search was performed, using the keywords "gastrointestinal vascular malformation", "octreotide", "angiodysplasia", "portal hypertensive gastropathy", "gastric antral vascular ectasia", and "hereditary vascular malformations"...
September 2016: Clinics and Research in Hepatology and Gastroenterology
https://www.readbyqxmd.com/read/27559487/a-unique-presentation-of-anti-rna-polymerase-iii-positive-systemic-sclerosis-sine-scleroderma
#9
Cody M Lee, Diana Girnita, Arundhati Sharma, Surabhi Khanna, Jean M Elwing
Systemic sclerosis is a rare autoimmune disorder with a wide spectrum of clinical manifestations and a multitude of autoantibodies that are associated with it. In the past several years, advances in serologic testing have led to research indicating important prognostic and phenotypic associations with certain subsets of autoantibodies. In particular, anti-RNA polymerase III (anti-RNAP III) has been associated with diffuse cutaneous disease, scleroderma renal crisis, a temporal relationship with malignancy, myositis, synovitis, joint contractures, and gastric antral vascular ectasia...
2016: Case Reports in Rheumatology
https://www.readbyqxmd.com/read/27476085/clinical-characterization-of-gastric-antral-vascular-ectasia-a-potential-manifestation-of-the-metabolic-syndrome
#10
Elliot Smith, Bezawit Tekola, James Patrie, Scott Cornella, Stephen Caldwell
BACKGROUND AND OBJECTIVES: Gastric antral vascular ectasia is a relatively common endoscopic finding. Past studies have shown an association of gastric antral vascular ectasia with cirrhosis and autoimmune disorders. We aimed to re-examine these associations and to investigate a possible association of gastric antral vascular ectasia with features of the metabolic syndrome. METHODS: There were 135 patients with a diagnosis of gastric antral vascular ectasia from years 1995-2013 seen at the University of Virginia who were identified from a clinical data repository and age and sex matched to a cohort of patients without gastric antral vascular ectasia undergoing endoscopy within the same time frame as the index cases...
December 2016: American Journal of Medicine
https://www.readbyqxmd.com/read/27403309/randomized-controlled-study-of-endoscopic-band-ligation-and-argon-plasma-coagulation-in-the-treatment-of-gastric-antral-and-fundal-vascular-ectasia
#11
Mohammed Elhendawy, Samah Mosaad, Walaa Alkhalawany, Lobna Abo-Ali, Mohamed Enaba, Aymen Elsaka, Asem A Elfert
BACKGROUND: Gastric antral vascular ectasia (GAVE) is characterized by mucosal and submucosal vascular ectasia causing recurrent hemorrhage and thus, chronic anemia, in patients with cirrhosis. Treatment with argon plasma coagulation (APC) is an effective and safe method, but requires multiple sessions of endoscopic therapy. Endoscopic band ligation (EBL) was found to be a good alternative for APC as a treatment for GAVE, especially in refractory cases. The aim of this prospective randomized controlled study was to evaluate the safety and efficacy of EBL, as compared to APC, in the treatment of GAVE and gastric fundal vascular ectasia (GFVE)...
June 2016: United European Gastroenterology Journal
https://www.readbyqxmd.com/read/26855694/portal-hypertensive-gastropathy-a-systematic-review-of-the-pathophysiology-clinical-presentation-natural-history-and-therapy
#12
Mihajlo Gjeorgjievski, Mitchell S Cappell
AIM: To describe the pathophysiology, clinical presentation, natural history, and therapy of portal hypertensive gastropathy (PHG) based on a systematic literature review. METHODS: Computerized search of the literature was performed via PubMed using the following medical subject headings or keywords: "portal" and "gastropathy"; or "portal" and "hypertensive"; or "congestive" and "gastropathy"; or "congestive" and "gastroenteropathy". The following criteria were applied for study inclusion: Publication in peer-reviewed journals, and publication since 1980...
February 8, 2016: World Journal of Hepatology
https://www.readbyqxmd.com/read/26820079/endoscopic-band-ligation-for-gastric-antral-vascular-ectasia-time-for-a-new-indication
#13
LETTER
Chiara Marzano, Maddalena Zippi, Giampiero Traversa
No abstract text is available yet for this article.
February 2016: Endoscopy
https://www.readbyqxmd.com/read/26807380/patients-with-gastric-antral-vascular-ectasia-gave-are-at-a-higher-risk-of-gastrointestinal-bleeding-in-the-absence-of-cirrhosis
#14
Jennifer Wang, Jonathan G Stine, Scott L Cornella, Curtis K Argo, Steven M Cohn
BACKGROUND AND AIMS: Gastric antral vascular ectasia (GAVE) is commonly found in patients with cirrhosis, but it is also associated with other diseases in the absence of cirrhosis. Whether GAVE confers a different severity of gastrointestinal (GI) bleeding between patients with and without cirrhosis remains unknown. We aim to examine whether there is a difference in clinically significant GI bleeding due to GAVE in patients with or without cirrhosis. METHODS: This is a retrospective case-control study of patients who were diagnosed with GAVE between January 2000 and June 2014...
December 28, 2015: Journal of Clinical and Translational Hepatology
https://www.readbyqxmd.com/read/26726089/gastric-antral-vascular-ectasia-during-the-treatment-of-chronic-myelogenous-leukemia-with-imatinib-mesylate
#15
Kensuke Narukawa, Kazuhiko Kakihana, Takashi Fujiwara, Takeshi Kobayashi, Noriko Doki, Hisashi Sakamaki, Kazuteru Ohashi
This report describes three patients with chronic myelogenous leukemia who developed gastric antral vascular ectasia (GAVE) during treatment with imatinib mesylate (IM). Cessation and/or switching from IM to nilotinib resulted in the alleviation of gastrointestinal (GI) bleeding and ectatic lesions. Furthermore, GI bleeding recurred after the re-administration of IM in one patient. Thus, we consider that the occurrence of GAVE in our patients was induced by IM. Although the precise mechanism of IM-GAVE is not understood, all patients took at least 400 mg/day of IM at the onset of GAVE...
2016: Internal Medicine
https://www.readbyqxmd.com/read/26633973/gastric-antral-vascular-ectasia-in-systemic-sclerosis-current-concepts
#16
REVIEW
Raphael Hernando Parrado, Hernan Nicolas Lemus, Paola Ximena Coral-Alvarado, Gerardo Quintana López
Introduction. Gastric antral vascular ectasia (GAVE) is a rare entity with unique endoscopic appearance described as "watermelon stomach." It has been associated with systemic sclerosis but the pathophysiological changes leading to GAVE have not been explained and still remain uncertain. Methods. Databases Medline, Scopus, Embase, PubMed, and Cochrane were searched for relevant papers. The main search words were "Gastric antral vascular ectasia," "Watermelon Stomach," "GAVE," "Scleroderma," and "Systemic Sclerosis...
2015: International Journal of Rheumatology
https://www.readbyqxmd.com/read/26564121/portal-hypertensive-gastropathy-and-gastric-antral-vascular-ectasia
#17
Hitendra Garg, Subhash Gupta, A C Anand, S L Broor
Portal hypertensive gastropathy (PHG) and gastric antral vascular ectasia (GAVE) are gastric mucosal lesions that mostly present as chronic anemia and rarely cause the acute gastrointestinal hemorrhage. Despite similar clinical manifestations, their pathophysiology and management are entirely different. PHG is seen exclusively in patients with portal hypertension, but GAVE can also be observed in patients with other conditions. Their diagnosis is endoscopic, and although generally each of them has a characteristic endoscopic appearance and distribution, there are cases in which the differential is difficult and must rely on histology...
September 2015: Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology
https://www.readbyqxmd.com/read/26509542/-treatment-of-gastric-antral-vascular-ectasia-with-endoscopic-banding
#18
Johan F Hermansen, Henning Glerup
Gastric antral vascular ectasia (GAVE) is an important cause of gastro-intestinal bleeding. An 81-year-old male twice experienced severe anaemia as a result of GAVE. On the second occasion he was treated with endoscopic banding, and since he kept a stable haemoglobin level. GAVE has previously been treated which several different methods. Recently, endoscopic band ligation has, however, emerged as a new treatment of GAVE. Endoscopic band ligation has proven to be a safe and efficient treatment of GAVE.
October 26, 2015: Ugeskrift for Laeger
https://www.readbyqxmd.com/read/26429218/intravenous-cyclophosphamide-as-a-therapeutic-option-for-severe-refractory-gastric-antral-vascular-ectasia-in-systemic-sclerosis
#19
D A Papachristos, M Nikpour, C Hair, W M Stevens
Gastric antral vascular ectasia (GAVE) is a rare but important cause of upper gastrointestinal bleeding. It is commonly associated with autoimmune conditions such as systemic sclerosis, and standard treatment involves both supportive measures, as well as endoscopic interventional therapies. While the current therapies are effective for most patients, a few patients develop severe and refractory bleeding. Herein we report two cases of refractory GAVE in patients with diffuse scleroderma, which improved significantly after the administration of intravenous cyclophosphamide...
October 2015: Internal Medicine Journal
https://www.readbyqxmd.com/read/26376475/portal-hypertensive-gastropathy-and-gastric-antral-vascular-ectasia
#20
REVIEW
Samuel Han, Nabeel Chaudhary, Wahid Wassef
PURPOSE OF REVIEW: Portal hypertensive gastropathy (PHG) and gastric antral vascular ectasia (GAVE) are two types of upper gastrointestinal bleeding that may present similarly, but are managed very differently. This article reviews the pathogenesis and guidelines in management of both of these conditions with emphasis on recent advances in the field. RECENT FINDINGS: Off-label use of Hemospray has been shown in several case series to be useful in managing acute bleeding from PHG...
November 2015: Current Opinion in Gastroenterology
keyword
keyword
33647
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"